Multiple myeloma survival in New South Wales, Australia, by treatment era to 2020

This work is part of the Cancer-Patient Population Projections project funded by a Medical Research Future Fund (MRFF) Preventive and Public Health Research Initiative: 2019 Target Health System and Community Organisation Research Grant Opportunity (Grant No. MRF1200535). Karen Canfell is supported by National Health and Research Council of Australia Leadership Investigator Grants (NHMRC; Grant No. APP1194679) and is co-PI of an investigator-initiated trial of cervical screening, “Compass,” run by the Australian Centre for the Prevention of Cervical Cancer (ACPCC), a government-funded not-for-profit charity. Compass receives infrastructure support from the Australian government, and the ACPCC has received equipment and a funding contributions from Roche Molecular Diagnostics, USA. KC is also co-PI on a major implementation program, Elimination of Cervical Cancer in the Western Pacific, which has received support from the Minderoo Foundation and equipment donations from Cepheid Inc.